Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (642)	12/1/1998 12:31:00 PM
From: Dan Spillane	Read Replies (1) \| Respond to of 2539

If the following is correct, the partial news that was reported is a joke. Ha ha! I'm laughing. Let's mislead everyone! What is in question is not apparently related to the question of approval for most uses, only that the drug wouldn't be used for severe pain such as that after surgery. No kidding! Give me the Vicodin! (from the news) The second question, however, notes that the FDA doesn't think there's enough evidence yet to support approval specifically for ''acute pain,'' or the immediate treatment of pain such as that following surgery. The question asks whether the panel agrees.